Cytochemical Localization of Hyaluronan in Rat and Human Skin Mast Cell Granules  by Eggli, Peter S. & Graber, Werner
cytochemical Localization ofHyaluronan in Rat and 
Human Skin Mast Cell Granules 
Peter S. Eggli and Werner Graber 
Institute of Anatomy, University of Bern, Bern, Switzerland 
Rat and human skin ,,:ere processed either by os~iuI? tetrox-
ide/microwave fixation followed by embeddmg m epoxy 
resin or by glutaraldehyde/microwave fixation and low-
temperature embedding in Lowicryl K4M. Hyaluronan-
binding proteins and link proteins (LP) were isolated from 
bovine nasal cartilage, coupled to 15 - 20-nm gold particles 
and employed as markers in a one-step post-embedding pro-
cedure for identifying hyaluronan (hyaluronic acid) at the 
ultrastructural level. M ast cell granules of both species were 
labeled . The specificity of the hyaluronan-binding probes 
H yaluronan is a negatively-charged non-sulfated gly-cosaminoglycan composed of simple disaccharide units (D-glucuronic acid and N-acetyl-D-glucosa-mine), which is encountered in most connective tissues. 
In rats, and probably in other mammals also, the largest pool of 
hyaluronan is located in the skin (50% of total body content [1 D, 
where it constitutes = 0.1 % of the wet weight; even higher concen-
trations are found during the early stages of wound healing [2-4]. 
The source of skin hyaluronan is largely speculative [4] , but dermal 
fibroblasts have been implicated as the most likely candidates, 
owing to their known capacity for synthesizing and secreting this 
glycosaminoglycan [5,6] . However, a tissue richness in hyaluronan 
has also been coupled to the presence of abundant mast cells, an 
observation made as far back as 1950 by Asboe-Hansen [7], and the 
occurrence of this glycosaminoglycan in these cells has since been 
confirmed by histochemical and biochemical analysis in rat and 
human tissue [8 -10]. These findings are, nonetheless, not generally 
accepted, and fail to be cited in recent review articles [11-13]. 
In this study, the hyaluronan-binding protein [14] and link pro-
tein (both directly coupled to gold r articles 15 - 20 nm in diameter) 
were used as specific cytochemica markers for the localization of 
hyaluronan in mast cell granules. 
MATERIALS AND METHODS 
Osmium Tetroxide/Microwave Fixation and Embedding in 
Epoxy Resin Wistar rat conjunctiva and Wistar rat abdominal 
wall and human forearm skin were fixed for 2 min at ambient 
temperature in 2% (v Iv) osmium tetroxide solution (in 0.2 M so-
dium cacodylate buffer, pH 7.2, 450 mOsm). Glass vials (24 mm X 
40 mm) containing the tissue and 10 ml of fixative solution were 
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was demonstrated by treatment of sections with testicular 
hyaluronidase, Streptomyces hyaluronidase, and chondroitin-
ase ABC, and pre-incubation of probes with hyaluronan oli-
gosaccharides. 
. The results suggest that mast cell granules are a rich source 
of hyaluronan; this finding may account for the striking con-
currence of h yaluronan accumulation with a mastocytotic 
condition in many tissues undergoing pathologic changes. 
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then placed in the center of a conventional microwave oven and 
heated for 11.5 seconds at maximal power output (650 W) and at a 
frequency of 2450 MHz; temperatures between 43°C and 46°C 
were attained [15 ,16]. Samples were maintained in the fixative at 
ambient temperature for 10 min prior to washing in 0.1 M sodium 
cacodylate buffer. They were then dehydrated in a graded series of 
increasing ethanol concentration, and embedded in epoxy resin 
(Epon 812). 
Glutaraldehyde/Microwave Fixation and Embedding in Lo-
wicryl K4M Wistar rat conjunctiva and human forearm skin 
were fixed for 5 min at ambient temperature in 2.5% (v Iv) glutaral-
dehyde solution (in 0.1 M sodium cacodylate buffer, pH 7.4, 520 
mOsm). They were then transferred to a microwave oven and 
heated for 14 seconds as described above; temperatures between 
51 °C and 53 °C were attained [15 ,1 7]. Samples were maintained at 
ambient temperature for 5 min prior to incubation for 2 h in 0.07 M 
sodium cacodylate buffer containing 30% (v Iv) aqueous dimethyl-
formamide [18] and 1.75% glutaraldehyde. The specimens were 
then dehy~rated m a grad~d series of increasing dimethylformamide 
concentration at progreSSIvely lower temperatures and embedded in 
Lowicryl K4M, w hich was polymerized by ultraviolet light at 
-20°C [18] . 
Preparation ofHyaluronan-Binding Protein (HABP) - Gold 
and Link Protein (LP) - Gold Complexes HABP and LP were 
prepare.d from bovine nasal cartilage as described by Tengblad [19] . 
Followmg extractIOn of proteoglycans with 4 M guanidinium chlo-
ride, the hyaluronan-binding proteins were isolated by affinity chro-
matography and further purified by gel chromatography. 
Coll.Oldal gold particles, 15-20 nm in diameter, were prepared 
accordmg to the method ofFrens [20]. The minimal concentrations 
of the respective proteins required to stabilize the gold sol [21] at pH 
7.0 were 7.ug/ml and 12.ug/ ml for HABP and LP, respectively. 
The gold complexes were prepared by adding aqueous solutions of 
either HABP (2 ml, 70.ug/ml) or LP (1.5 ml , 160 .ug/ml) to the 
collOIdal gold sol (20 ml, pH 7.0). A 2% (w/v) aqueous solution of 
bovine serum albumin (20 ml, fraction V; Sigma) was added after 5 
min, and the complexes centrifuged at 30,000 X g for 45 min at 
4°C (Kontron H 401, fixed angle rotor, Kontron A 8.24, Kontron, 
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Figure 1. Rat conjunctiva mast cells labeled for 24 h with either LP-gold 
(aJ or HABP-gold (bJ complexes (osmium tetroxide/microwave fixation; 
epoxy resin embedding). Bar, 0.5 11m. 
Switzerland). The wispy sediments were separated from the com-
pacted pellets (which were discarded), suspended in distilled water 
and recentrifuged as described above. They were then resuspended 
in phosphate-buffered saline (PBS) (1 ml, HABP-gold) or distilled 
water (1 ml, LP-gold) and stored at 4°C for up to 14 d. 
The number of molecules of LP (molecular weights of 45,000 
and 50,000) and HABP (molecular weight> 106) per gold particle 
may be estimated to be 75 and 2, respectively [22] . 
cytochemical Labeling U ltrathin sections were initially 
floated for 30 min on 1 % (w Iv) bovine serum albumin in PBS to 
block unspecific staining, and then incubated on an undi luted drop 
of either HABP-gold or LP-gold for various time periods (2 h for 
Lowicryl K4M and between 4 hand 24 h for epoxy resin sections) 
at an ambient temperature. They were subsequently washed by float-
ing initially on PBS (six changes) and then on distilled water (four 
changes) and finally dried. Sections were stained with uranyl acetate 
and lead citrate and examined in a Philips EM 300 or EM 400 
electron microscope. 
cytochemical Controls of Specificity 
Digestion with Streptomyces Hyaluronidase [23-25] : Ultrathin 
sections were di gested for 6 h at 37 °C in a humidified chamber 
with Streptomyces hyaluronidase (100 TRU/ml, Calbiochem; 650 
units/ml, Sigma) in 50 roM sodium acetate buffer, pH 5.0. 
Digestion with Testicular Hya lurollidase [25,26}: Ultrathin sections 
were digested for 6 h at 37°C in a humidified chamber with 10 
mg/ml testicular hyaluronidase (Fluka) in Soerensen's phosphate 
buffer (0.1 M, pH 5.66). 
Figure 2. Human skin mast cells labeled for 8 h with LP-gold complexes 
(osmium tetroxide/microwave fixation; epoxy resin embedding) (aJ or for 
2 h with HABP-gold complexes (glutaraldehyde/microwave fixation; 
Lowicryl K4M embedding) (b). Bar, 0.5 11m . 
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Figure 3. Rat skin fibroblast labeled for 6 h with LP-gold complexes 
(osmium tetroxide/microwave fixation; epoxy resin embedding). Bar, 
0.5 11m. 
Digest io~1 with Chol1droitillase ABC [24]: Ultrathin sections were 
digested for 6 h at 37"C in a humidified chamber with 2 U/ml 
chondroitinase ABC (Sigma) in enriched Tris buffer (pH 8.6 
[24,27]). 
All digestion experiments included the appropriate controls (ab-
sence of the respective enzymes) under identical incubation condi-
tions. To quantify the effect of the different enzyme digestions, 
ultrathin sections of rat skin (osmium tetroxide/microwave fixa-
tion, epoxy resin embedding) were labeled -after incubation with 
either the enzyme or appropriate buffer- for 4 h with LP-gold, 
and the number of go ld particles per unit area of sectioned mast ceU 
granules counted. 
Blocking of Labelillg with Hyaillronan Oligosaccharides [14}: A 2% 
(w Iv) solution of rooster comb hyaluronan (Sigma) in Soerensen's 
phosphate buffer (0.1 M in 0.15 M NaCI, pH 5.0) was digested 
with 4 mg/ml testicular hyaluronidase (Fluka) for 24 h at 37 °C to 
obtain hyaluronan oligosaccharides, and the mixture then heated in 
a boiling water bath for 15 min to inactivate and precipitate the 
enzyme [28]. The oligosaccharide-containing supernatant was 
combined (1: 1) with either HABP-go ld or LP-gold for 2 h at am-
bient temperature prior to incubation of sections. 
RESULTS 
Localization ofHyaluronan in Mast Cell Granules All mast 
cells originating from rat conjunctiva (Fig la,b) and from rat and 
human (Fig 2a,b) skin exhibited specific labeling of their granules 
with LP-gold (Figs la and 2a) or HABP-gold (Figs Ib and 2b) 
complexes, irrespective of the fixation and embedding technique 
employed [osmium tetroxide/microwave fixation followed by em-
bedding in a hydrophobic epoxy resin (Figs 1 and 2a) or glutaralde-
hyde/microwave fixation fo llowed by embedding in a polar meth-
acry late resin (Lowicryl K4M) (Fig 2b)]. 
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Figure 4. Cytochemical controls for specificity. a,b) Rat conjunctiva mast cells (glutaraldehyde/microwave fixation; Lowicryl K4M embedding) 
incubated with either Soerensen's phosphate buffer (8 h) (a) or with testicular hyaluronidase (8 h) (b) and subsequently labeled for 2 h with HABP-gold 
complexes. c,d,e) Rat skin mast cells (osmium tetroxide/microwave fixation; epoxy resin embedding) incubated with either sodium acetate buffer (6 h) 
(c), Streptomyces hyaluronidase (6 h) (d), or testicular hyaluronidase (6 h) (e) and subsequently labeled for 4 h with LP-gold complexes. J) Rat skin mast 
cells (osmium tetroxide/microwave fixation; epoxy resin embedding) after application (4 h) of a LP-gold complex pre-incubated with hyaluronan 
oligosaccharides. Bar, 0.5 )lm. 
Mast cell plasma membranes and cytoplasm, notably the Golgi 
apparatus (Fig 2a), were seldom labeled. It is of interest to note here 
that rat skin fibroblast plasma membranes exhibited distinct labeling 
on both intra- and extracellular aspects (Fig 3). 
Controls Sections treated with testicular hyaluronidase exhibited 
virtually no labeling of mast cell granules (Fig 4b,e), but Streptomyces 
hyaluronidase was less effective (Fig 4d). Chondroitinase ABC re-
sulted in an only moderate reduction of labeling intensity. Highest 
labeling was observed in the buffer controls (absence of the respec-
tive enzymes) (Fig 4a,c). The effects of enzyme digestion on LP-
gold labeling of osmium tetroxide/microwave fixed and epoxy 
resin embedded rat skin were quantified by counting the number of 
gold particles per unit area of granules (Table I). No differences 
were observed between the two commercial samples of Streptomyces 
hyaluro~idase emp~oyed . Pre-incubation of the probes with hyalur-
onan ohgosacchandes completely blocked labeling with both 
HABP-gold and LP-gold (Fig 4J). 
DISCUSSION 
The biotinylated hyaluronan-binding region ofLP and HABP, used 
in conjunction wi~h av~din-pero:cidase, was introduced by Ripellino 
et al [14] as a speCific ~Istochelrucal probe for locating the presence 
of hyaluronan at the hght and electron microscopic levels. We have 
mo~ified this techni9ue.and direct/x couple LP and HABP to gold 
particles 15 - 20 om 111 diameter, to Improve ultrastructurallocaliza-
tion [29]. 
LP and HABP ex~ibit hi~h affinity and specific binding to hya-
luronan [28,30] . In bIOchemIcal assays, LP has revealed no capacity 
Table I. Quantitative Evaluation of Rat Skin Mast Cell Granule Labeling (Osmium TetrOxide/Microwave Fixation; Epoxy Resin 
Embedding) with LP-Gold After Digestion with Testicular HyalurOnidase, Streptomyces Hyaluronidase, or Chondroitinase ABC 
Testicular hyaluronidase 
Streptomyces hyaluronidase 
Chondroitinase ABC 
• Student t test was applied. 
Buffer Control: Gold Particles 
per )lm2 Mast Cell Granules 
231 (SO = 76) 
174 (SO = 85) 
159 (SO = 53) 
Enzyme Digestion: Gold 
Particles per )lm2 Mast Cell 
Granules 
12(50=5) 
44 (SO = 29) 
106 (SO = 50) 
Reduction of Labeling Relative 
to Control Values 
94.8% (p < 0.001 ; n = 12") 
74.4% (p < 0.001 ; n = IS") 
33.3% (p < 0.02; n = 12") 
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for binding to other glycosaminoglycans, such as chondroitin 4- or 
6-sulfate, dermatan sulfate, keratan sulfate, or heparan sulfate, and 
only a very weak non-specific electrostatic interaction with heparin 
has been achieved [28]. The histochemical specificity of our hyalur-
onan-binding probes has been previously demonstrated by hyaluron-
idase treatment of sections [29]. Testicular hyaluronidase-which 
degrades hyaluronan and chondroitin sulfate [26], but not heparin 
[31] - blocked labeling. of mast cell granules al~ost completely, 
whereas the highly speCific Streptomyces hyaluromdase [23] was less 
effective. Digestion with chondroitinase ABC-which at a pH of 
8.6 degrades only negligible amounts of hyaluronan [24,32]-
resulted in only a moderate, but still significant, reduction of rat skin 
mast cell granule labeling (Table I). The digestion experiments 
suggest that hyaluronan is incompletely removed from mast cell 
granules by hyalur~n~dase or cho~~r?itin~se activi~ alone, a more 
potent attack combll:l11g bo.th actiVities bei~g re'JUlred, as e.xempli-
ned by treatment With testlCular hyaluromdase [26]. The implica-
tion is that hyaluronan interacts with chondroitin sulfate [33] by 
hydrophobic bonding [34]. Non-specific labeling of chondroitin 
sulfates would appear to be unlikely, considering a) the high speci-
ficity of both LP [28] and HABP [25,30) for hyaluronan, b) that 
chondroitin sulfate oligosaccharides were unable to block the bind-
ing activities of biotinylated hyaluronan-binding probes [14,35], 
and c) that extracellular labeling of connective tissue chondroitin 
sulfates was not observed (current study; [25,36]) . Moreover, com-
plete blocking of the labeling activity of both probes by pre-incuba-
tion with hyaluronan oligosaccharides demonstrates their high af-
finity for hyaluronan [14,37,38], and excludes the possibility of 
non-specific attachment to the sections [39]. 
Our hyaluronan-binding probes bind almost exclusively to the 
secretory granules of mast cells. Significant labeling of the Golgi 
area was not observed, this being consistent with current concepts 
that hyaluronan is synthesized at the plasma membrane [5,40] rather 
than in the Golgi compartment [41]. And indeed, rat skin fibroblasts 
exhibited distinct labeling of the plasma membranes and nearby 
intra- and extracellular compartments with our hyaluronan-bind-
ing probes. However, the labeling pattern observed in mast cells 
suggests that, in this instance, hyaluronan synthase may be located 
in the secretory granule membrane. 
The presence of hyaluronan in mast cell granules is not entirely 
unexpected, because there have been numerous indications of an 
association between hyaluronan accumulation and the presence of 
mast cells in various tissues undergoing pathologic changes, such as 
in cases of thyreotoxic myxoedema [7], rheumatoid arthritis 
[35,42], allergic asthma [43], sarcoidosis [44], scleroderma [45,46]' 
and sclerodema adultorum Buschke [47], and also in skin tumors [7] 
and experimentally injured lungs [48,49), and during the early 
stages of cutaneous inflan:mation and wound healing [3,7,12]. 
Taking these observations together with the findings of the 
current investigation, it would seem reasonable to deduce that the 
elevated levels of tissue hyaluronan associated with early stages of 
wound healing may derive from mast cell secretory activity. 
Whether stimulated fibroblasts also contribute to the accumulation 
of hyaluronan [47,48] is not known. 
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